drugset / Trial / NCT01715597

Study on the Effect of Intravenous Ascorbic Acid on Intraoperative Blood Loss in Women With Uterine Myoma

NCT01715597 ↗

Phase 3 Completed 50 enrolled Seoul National University Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The investigators want to know whether the intravenous ascorbic acid would reduce the blood loss during laparoscopic myoma surgery. The investigators randomized patients into intravenous ascorbic acid group and placebo group and examined the blood loss in both groups.

Timeline

Start
2012-12
Primary completion
2017-10
Completion
2017-10

Outcome

Missed primary endpoint

paper as was the intraoperative blood loss (193±204mL vs. 159±193mL, P=0.52). PMID 26946313 ↗

paper Intravenous ascorbic acid infusion did not reduce intraoperative blood loss in women undergoing laparoscopic myomectomy. PMID 26946313 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Vitamin C Other / unclassified 2 g Intravenous